Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Adverum Biotechnologies
Company Name
Main Industry
Research & Development, Business Services
Website
www.adverum.comAdverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration and diabetic macular edema.
Adverum Biotechnologies Inc
Adverum Biotechnologies
AdVertum
Avalanche Biotechnologies Inc
Adversum
$26 M
121
2006
Adverum Biotechnologies raised a total of $252.2 M in funding over 2 rounds, and is a public traded company.
NASDAQ: ADVM
Here's a list of some of the top trending technologies and APIs used by Adverum Biotechnologies.
(8 Technologies)
(6 Technologies)
(4 Technologies)
(4 Technologies)
(4 Technologies)
Company | Employees | Revenue | Top technologies |
---|---|---|---|
agtc | 102 | $325 K | |
Voyager Therapeutics | 162 | $143.8 M | |
REGENXBIO | 344 | $89 M | |
Rocket Pharmaceuticals | 268 | $269.8 M | |
Generation Bio | 174 | $13.2 M |